Stocktoria
Rafael Holdings, Inc. RFL
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-03-12
Rafael Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $917,000 | $637,000 | $279,000 | $410,000 | $802,000 |
| R&D expense | $12.8M | $4.2M | $6.3M | $8.7M | $4.9M |
| SG&A expense | — | — | — | $17.0M | $17.0M |
| Operating income | -$29.2M | -$102.6M | -$15.0M | -$60.5M | -$28.2M |
| Interest expense | $658,000 | $248,000 | — | $6,000 | $12,000 |
| Income tax | -$2.6M | -$2.7M | -$255,000 | — | $18,000 |
| Net income | -$30.5M | -$34.4M | -$1.9M | -$124.7M | -$23.1M |
| EPS (diluted) | $-1.04 | $-1.45 | $-0.08 | $-6.31 | $-1.49 |
| Operating cash flow | -$18.9M | -$7.8M | -$10.9M | -$26.1M | -$15.6M |
| Free cash flow | -$18.9M | -$7.9M | — | -$26.1M | -$15.8M |
| Cash & equivalents | $52.8M | $2.7M | $21.5M | $26.5M | $7.9M |
| Inventory | $281,000 | — | — | — | — |
| Total assets | $114.1M | $96.8M | $98.8M | $118.3M | $154.1M |
| Total liabilities | $15.7M | $10.6M | $2.2M | $21.1M | $17.4M |
| Shareholders' equity | $98.4M | $86.3M | $100.3M | $100.5M | $136.7M |
Source: SEC EDGAR filings · CIK 0001713863 · as of 2025-07-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.